Pulmatrix

PULM · NASDAQ

$1.43+$0.01 (+0.70%)TodayMarket closed · Oct 20, 4:04 PM ET

Prev close $1.42

Latest news

Press releaseSep 29, 1:51 PM ETPRNewswire
Are MGLD, NRIM, PULM Obtaining Fair Deals for their Shareholders?
Press releaseSep 28, 7:30 PM ETPRNewswire
ACT NOW: The M&A Class Action Firm Is Investigating the Merger--LXP, LXFR, NRIM, and PULM
Press releaseSep 22, 8:30 AM ETGlobe Newswire
Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria
Press releaseAug 13, 8:15 AM ETPRNewswire
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger
Press releaseJul 10, 1:38 PM ETPRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN
Press releaseMay 15, 8:20 AM ETPRNewswire
Pulmatrix Announces First Quarter 2026 Financial Results
Press releaseApr 21, 8:00 AM ETPRNewswire
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
Press releaseApr 13, 9:55 AM ETBusiness Wire
PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders
NewsMar 26, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
Press releaseMar 26, 8:00 AM ETPRNewswire
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
NewsMar 2, 12:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseMar 2, 8:00 AM ETPRNewswire
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
Press releaseFeb 26, 8:05 AM ETPRNewswire
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results
Press releaseDec 18, 8:05 AM ETPRNewswire
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
Press releaseOct 16, 8:05 AM ETPRNewswire
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets
NewsAug 13, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseAug 6, 8:05 AM ETPRNewswire
Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets
NewsJul 1, 8:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsMay 15, 8:21 AM ET
Pulmatrix Q1 EPS $(0.50) Down From $0.23 YoY
Press releaseMay 15, 8:05 AM ETPRNewswire
Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets
Press releaseMay 13, 11:30 AM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders
Press releaseMay 9, 4:00 PM ETBusiness Wire
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM
Press releaseMar 21, 8:05 AM ETPRNewswire
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets
NewsMar 18, 5:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseFeb 25, 2:27 AM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders
Press releaseFeb 19, 9:59 AM ETBusiness Wire
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders
Press releaseNov 21, 11:44 AM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders
Press releaseNov 14, 6:55 PM ETBusiness Wire
PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM
Press releaseNov 13, 9:53 PM ETBusiness Wire
Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders
Press releaseNov 13, 6:55 PM ETPRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders
Press releaseNov 13, 10:25 AM ETBusiness Wire
PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders
Press releaseNov 13, 9:00 AM ETPRNewswire
Pulmatrix and Cullgen Announce Proposed Merger

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Are MGLD, NRIM, PULM Obtaining Fair Deals for their Shareholders?

ACT NOW: The M&A Class Action Firm Is Investigating the Merger--LXP, LXFR, NRIM, and PULM

Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger

SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN

Pulmatrix Announces First Quarter 2026 Financial Results

Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger

PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders

12 Health Care Stocks Moving In Thursday's Intraday Session

Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

12 Health Care Stocks Moving In Monday's Intraday Session

Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities

Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results

Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives

Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets

12 Health Care Stocks Moving In Wednesday's After-Market Session

Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Pulmatrix Q1 EPS $(0.50) Down From $0.23 YoY

Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets

12 Health Care Stocks Moving In Tuesday's After-Market Session

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, PULM, CCNE, TURN on Behalf of Shareholders

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, ALVR, PULM, ENTO on Behalf of Shareholders

PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM

Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AE, LBRDA, PULM, ENTO on Behalf of Shareholders

PULM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pulmatrix, Inc. Is Fair to Shareholders

Pulmatrix and Cullgen Announce Proposed Merger